We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where ...

We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...

"Chronic pain is a deeply personal and unique experience, requiring equally individualized treatment options," said Pedro Malha, vice president, neuromodulation, Abbott. "Every spinal cord stimulation ...

Neuromodulation Sales Growth ... 2025 Adjusted Tax Rate Forecast: 16% to 17%. Abbott Laboratories (NYSE:ABT) achieved a 9.5% sales growth excluding COVID testing, demonstrating strong performance ...

Abbott Laboratories (NYSE ... and growth from Esprit are below-the-knee resorbable stent. And lastly, in Neuromodulation, sales grew 8%, driven by strong demand in international markets for ...

Abbott cautions that these forward-looking ... growth from Esprit are below-the-knee resorbable stent. And lastly, in Neuromodulation, sales grew 8%, driven by strong demand in international ...

Abbott Laboratories ABT reported fourth-quarter ... The Electrophysiology, Rhythm Management and Neuromodulation divisions recorded organic growth of 8.8%, 7.2% and 8.4%, respectively, in the ...

neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott ...

neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott ...